levodopa has been researched along with selenium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, HL; Som, P | 1 |
| Jiménez-Jiménez, FJ; Molina, JA | 1 |
| Memon, SA; Parvez, SH; Qureshi, AA; Qureshi, GA | 1 |
1 review(s) available for levodopa and selenium
| Article | Year |
|---|---|
[Neuroprotective and neurorestorative therapy in Parkinson's disease].
Topics: Antiparkinson Agents; Apoptosis; Brain Tissue Transplantation; Chelation Therapy; Corpus Striatum; Dopamine; Erythrocytes; Free Radicals; Gangliosides; Genetic Therapy; Glutathione Peroxidase; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurons; Oxidative Stress; Parkinson Disease; Selegiline; Selenium; Vitamin E | 1997 |
2 other study(ies) available for levodopa and selenium
| Article | Year |
|---|---|
Growth-hormone and somatostatin effects on [75Se]selenomethionine uptake by the pancreas.
Topics: Animals; Apomorphine; Autoradiography; Carbon Radioisotopes; Dogs; Growth Hormone; Intestinal Mucosa; Kidney; Levodopa; Liver; Methionine; Mice; Pancreas; Radioisotopes; Selenium; Selenomethionine; Somatostatin | 1979 |
Impact of selenium, iron, copper and zinc in on/off Parkinson's patients on L-dopa therapy.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Case-Control Studies; Copper; Female; Humans; Iron; Levodopa; Male; Metals, Heavy; Middle Aged; Parkinson Disease; Selenium; Spectrophotometry, Atomic; Zinc | 2006 |